Advances in ADT: A Guide for Urologists and APPs
CME Available: https://auau.auanet.org/node/37866
At the conclusion of this activity, participants will be able to:
1. Identify and treat a patient with new diagnosed M1 prostate cancer with ADT plus be able to offer additional therapies that extend survival.
2. Analyze the risks and benefits of treatment fo ... Show More
Nov 4
Update Series (2026): Antibiotic Stewardship in Office Urology—A Case-Based Approach
Update Series (2026): Antibiotic Stewardship in Office Urology—A Case-Based Approach Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: E. Ann Gormley, MD, MSc Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fe ... Show More
20m 21s
Mar 2022
Robert Dreicer, MD, MS, MACP, FASCO - Decisions and Dilemmas in Prostate Cancer Management: Building on Progress to Advance Personalized Care Through Candid Conversations and Expert Clinical Consults
Go online to PeerView.com/GZF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Clinicians who treat patients with prostate cancer have new opportunities to improve outcomes across a variety of settings, but the rapid expansion ... Show More
1h 21m
Dec 2022
#371 Prostate Cancer: Screening, Advanced Testing, and Survivorship
Navigating guidelines, parsing through the PSA, Survivorship, & More!Become a pro when addressing prostate cancer! We tackle the nuances surrounding screening for this all-to-common cancer and discuss important considerations in survivorship with our guest Dr. Petar Bajic (Twitte ... Show More
1h 2m
May 2022
Bhavana Pothuri, MD, MS - Expanding the Benefits and Refining the Role of Immune Checkpoint Inhibitors in the Treatment of Recurrent and Advanced Endometrial Cancer
Go online to PeerView.com/KWF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in oncology discusses the role of immune checkpoint inhibitors in the care of patients with recurrent and advanced endo ... Show More
28m 20s
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
57m 23s
Apr 2022
Pasi A. Jänne, MD, PhD - Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies
Go online to PeerView.com/ZGP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The treatment arsenal for non–small cell lung cancer (NSCLC) with and without genomic alterations continues to expand, and novel HER2-, HER3-, and ... Show More
57m 55s